Cortexyme (NASDAQ:CRTX – Get Rating) and Immunocore (NASDAQ:IMCR – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, earnings and profitability. Earnings and Valuation This table compares Cortexyme and Immunocore’s top-line revenue, […]